HLS Therapeutics Confirms Annual Shareholders' Meeting

About this update from Hls Therapeutics, Inc.

[{"type":"text","content":"\n\n\n\nHLS Therapeutics Confirms Annual Shareholders' Meeting\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: TOP; BORDER-BOTTOM:1pt; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prngen3{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, ON, June 10, 2020\n\n\n\nTORONTO, ON, June 10, 2020 /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), a specialty pharmaceutical company focusing on central nervous system and cardiovascular markets, confirms that its Annual Meeting of Shareholders (the \"Meeting\") will take place at the offices of Blake, Cassels & Graydon LLP, 199 Bay Street, Commerce Court West, Suite 4000, Toronto, Ontario, on Friday June 19, 2020 at 10:00 a.m. (Toronto time).\nDue to COVID-19 and related government orders and public health directives regarding social distancing and the maximum size of public gatherings, certain officers and members of HLS's Board of Directors and HLS's auditors and other advisors will not attend the Meeting in person and, to the extent they are foreign residents, are not expected to be permitted to cross international borders for such purposes. \nAnyone attending the Meeting will be asked a series of questions prior to being admitted to the Meeting. In order to ensure the health and safety of all attendees, and to comply with applicable COVID-19-related restrictions, HLS and Blakes, as host of the Meeting, will reserve the right to restrict access to the Meeting.\nAs a result, shareholders are encouraged to vote in advance of the Meeting and to follow the Meeting via the webcast or teleconference. Shareholders have multiple options for voting in advance, which include on-line, via telephone or via mail. Details on using each method are included in the Management Information C...

More updates from Hls Therapeutics, Inc.